Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1580 participants
OBSERVATIONAL
2017-09-26
2027-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunological and Cardiovascular Phenotyping of Oocyte-donation Pregnancies
NCT04731012
Post-Pregnancy Cardio Trial
NCT03313063
Cardiovascular Risk After Preeclampsia
NCT05277233
Role of Anti-C1q Autoantibodies in Pregnancy
NCT06317467
The ADRB3 Receptor in Pregnancy
NCT02381106
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* pregnant with diagnosis of preeclampsia, gestational hypertension or gestational diabetes
Exclusion Criteria
* alcohol and drug abuse
* manifest and chronic diseases
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Florian Herse
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Experimental and Clinical Research Center (ECRC)
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BBPC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.